mTOR activation in CD8+ cells contributes to disease activity of rheumatoid arthritis and increases therapeutic response to TNF inhibitors.
Zhang M, Iwata S, Sonomoto K, Ueno M, Fujita Y, Anan J, Miyazaki Y, Ohkubo N, Sumikawa MH, Todoroki Y, Miyata H, Nagayasu A, Kanda R, Hao H, Trimova G, Lee S, Nakayamada S, Sakata K, Tanaka Y.
Zhang M, et al. Among authors: sumikawa mh.
Rheumatology (Oxford). 2022 Jul 6;61(7):3010-3022. doi: 10.1093/rheumatology/keab834.
Rheumatology (Oxford). 2022.
PMID: 34791054